BlackRock Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$54,618,236
-4.4%
2,137,700
+7.3%
0.00%0.0%
Q2 2023$57,137,302
+32.7%
1,992,235
+10.9%
0.00%
+100.0%
Q1 2023$43,057,718
+34.7%
1,796,317
-4.7%
0.00%0.0%
Q4 2022$31,967,647
+10.0%
1,884,885
-3.9%
0.00%0.0%
Q3 2022$29,056,000
-3.1%
1,960,589
+3.0%
0.00%0.0%
Q2 2022$29,973,000
-34.4%
1,904,302
+12.3%
0.00%0.0%
Q1 2022$45,715,000
-29.8%
1,695,639
-3.6%
0.00%
-50.0%
Q4 2021$65,121,000
-20.8%
1,759,590
+2.3%
0.00%0.0%
Q3 2021$82,216,000
+42.6%
1,720,708
+1.0%
0.00%0.0%
Q2 2021$57,647,000
-20.4%
1,703,509
-2.8%
0.00%0.0%
Q1 2021$72,383,000
-6.4%
1,752,604
-1.6%
0.00%0.0%
Q4 2020$77,301,000
+55.0%
1,781,955
+53.3%
0.00%0.0%
Q3 2020$49,859,000
+10.7%
1,162,228
+20.6%
0.00%0.0%
Q2 2020$45,028,000
+4288.7%
963,362
+1177.3%
0.00%
Q1 2020$1,026,000
+49.6%
75,424
+19.5%
0.00%
Q4 2019$686,000
+6.7%
63,094
+0.9%
0.00%
Q3 2019$643,000
+189.6%
62,550
+165.6%
0.00%
Q2 2019$222,00023,5480.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Green Alpha Advisors, LLC 21,538$550,2960.42%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders